Spoken Alpha
PURE BIOSCIENCE, INC.
Pure Bioscience manufactures antimicrobial disinfecting and sanitizing products based on patented stabilized ionic silver (Silver Dihydrogen Citrate) for food processing, food service, healthcare, and facility care.
PURE BIOSCIENCE, INC is a Consumer Defensive company operating in Household & Personal Products with a $10.4M market cap.
Most recent reported earnings: Q2 FY2026 (Mar 17, 2026).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add PURE, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PURE.
$ curl https://api.spokenalpha.com/v1/companies/PUREFAQ
Spoken Alpha indexes PURE's earnings call transcripts at https://spokenalpha.com/companies/PURE. Each call links to attributed speakers and parsed analyst Q&A. PURE BIOSCIENCE, INC.'s own investor relations page is at https://www.purebio.com/investors.
PURE BIOSCIENCE, INC. (PURE) operates in the Consumer Defensive sector (Household & Personal Products industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-03-17 | $-0.01 | $0.00 | — | $444.0K | — | — | EODHD |
| Q1 FY2026 | 2025-12-14 | $-0.00 | $0.00 | — | $708.0K | — | — | EODHD |
| Q4 FY2025 | 2025-10-28 | $-0.00 | — | — | — | — | — | EODHD |
| Q3 FY2025 | 2025-06-11 | $-0.01 | — | — | $491.0K | — | — | EODHD |
| Q2 FY2025 | 2025-03-16 | $-0.01 | — | — | $391.0K | — | — | EODHD |
| Q1 FY2025 | 2024-12-11 | $-0.01 | — | — | $556.0K | — | — | EODHD |
| Q4 FY2024 | 2024-10-28 | $-0.01 | — | — | $474.0K | — | — | EODHD |
| Q3 FY2024 | 2024-06-13 | $-0.01 | — | — | $441.0K | — | — | EODHD |
| Q2 FY2024 | 2024-03-17 | $-0.01 | — | — | $326.0K | — | — | EODHD |
| Q1 FY2024 | 2023-12-13 | $-0.01 | — | — | $722.0K | — | — | EODHD |
| Q4 FY2023 | 2023-10-29 | $0.00 | $0.00 | — | $602.0K | — | — | EODHD |
| Q3 FY2023 | 2023-06-13 | $-0.01 | — | — | $407.0K | — | — | EODHD |
| Q2 FY2023 | 2023-03-16 | $-0.01 | — | — | $397.0K | — | — | EODHD |
| Q1 FY2023 | 2022-12-13 | $-0.01 | — | — | $471.0K | — | — | EODHD |
| Q4 FY2022 | 2022-10-27 | $-0.01 | — | — | $412.0K | — | — | EODHD |
| Q3 FY2022 | 2022-06-13 | $-0.01 | — | — | $524.0K | — | — | EODHD |
| Q2 FY2022 | 2022-03-14 | $-0.01 | — | — | $416.0K | — | — | EODHD |
| Q1 FY2022 | 2021-12-14 | $-0.01 | — | — | $501.0K | — | — | EODHD |
| Q4 FY2021 | 2021-10-27 | $-0.03 | — | — | $859.0K | — | — | EODHD |
| Q3 FY2021 | 2021-06-14 | $-0.01 | — | — | $561.0K | — | — | EODHD |
Source: EODHD. PURE reported actuals as published; sparse fields render as —.